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Chapter 1 Introduction 
1.1 The goal and outline of the thesis 
 
Fig. 1 Outline of this thesis. 
 
The goals of this work were to apply directed evolution techniques to 
generate a large molecular diversity of non-natural carotenoid pathways and to 
establish a specific and efficient pathway for each of the compounds. One of the 
main targets of this thesis project was constructing specific pathways for 
C50-astaxanthin and its related compounds. In the following chapters, I will 
discuss how to generate a variety of carotenoid pathway enzymes. Specifically, 
I will describe how to make a 6-enzyme 15-step pathway (Fig. 1). 
In Chapters 2 and 3, I will describe how I performed directed 
evolution on the carotenoid synthase (CrtM) and farnesyl diphosphate synthase 
(FDS) to expand their reaction specificities. In Chapter 2, I will demonstrate 
how I created a series of CrtM variants with shifted substrate specificities 
ranging from C30 to C60 carotenoid backbone synthesis. An analysis of the 
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resultant mutants revealed a remarkable plasticity for the carotenoid synthase 
and provided unique insights into the specificity controlling mechanisms of this 
enzyme. In Chapter 3, I will describe how alternations in the specificity of FDS 
yield variants with shifted product specificities ranging from C15PP to C30PP.  
Chapter 4 describes my efforts to create C50 carotenoid pathways by 
combining different sized FDS and CrtM variants. I faced a specificity problem 
because none of the FDS/CrtM variants were specific for their assigned steps. 
Thus, their co-expression led to the formation of numerous (unwanted) 
byproducts without producing the target compound (C50-astaxanthin and its 
precursors). To overcome this problem, I tested a novel strategy to generate a 
specific pathway out of a non-specific enzyme. First, I created a series of size 
variants for FDS and CrtM through the combinatorial introduction of specificity 
mutations. Next, I systematically tested the pairwise co-expression of the 
enzyme variant pairs in hopes of discovering specific pairs that would yield 
specific products. This strategy was very effective at creating pathways not only 
for the C50 carotenoid backbone but also for the C30, C40, C35, and C60 backbones 
without having to engineer a specific enzyme. I demonstrated that this 
specificity stacking strategy is the only realistic approach for constructing 
long-step non-natural pathways.  
As is often the case for enzymes in natural product pathways (i.e., the 
secondary metabolites), modifying enzymes (downstream enzymes) for the 
carotenoid pathway are generally known to be promiscuous. Given the specific 
pathway for the C50 backbone, I attempted to extend this pathway by adding 
desaturase, cyclase, and decoration enzymes (Chapter 6) to produce 
C50-astaxanthin. I engineered the carotenoid desaturase CrtI (Chapter 5) for the 
desaturation of the C50 carotenoids. The wild-type CrtI had weak and limited 
activity on the C50 backbone. Therefore, I performed directed evolution on the 
CrtI enzyme using the established specific C50 pathway and obtained an 
efficient desaturase for the C50 pathway. Doing so provided new insights on the 
molecular basis of the substrate (size) specificity of this enzyme and how the 
step number for this enzyme is determined. I also proposed a mechanistic 
model to determine the reaction specificity of carotenoid desaturases. In 
Chapter 6, I describe how the C50 pathway can be further extended by the 
expression of additional carotenoid cyclase, oxidase, hydroxylase, and 
glycosilase enzymes. These experiments produced highly efficient pathways for 
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the production of C50-astaxnathin, which is a C50 analog with very high value as 
an antioxidant. These pathways were very specific (most of them were virtually 
single-product pathways). They were also high in efficiency.  
The successful establishment of efficient pathways for various C50 
carotenoids (Chapters 2 to 6) revealed the exceptional plasticity of carotenoid 
pathways and their constituents (enzymes). In Chapter 7, I describe the 
intersection of carotenoid pathways and cholesterol pathways. I found that 
co-expressing squalene synthase, the first committed enzyme in cholesterol 
synthesis and C30 carotenoid desaturase CrtN from Staphylococcus aureus yielded 
a C30 carotenoid pigment. Detailed analysis of this pathway suggested a 
non-natural route for carotenoid pathways by way of desaturating squalene. 
Based on the results described in Chapter 4, I will discuss how natural 
pathways could have evolved, how they could have obtained access to novel 
compounds, and how they could have quickly achieved pathway specificity for 
each of the pathways toward the tried-and-true compounds.  
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Chapter 2 Directed evolution of carotenoid synthase 
2.1 Abstract 
Most natural carotenoids have 40-carbon (C40) backbones, though 
some bacteria-produced carotenoids have C30 backbones. No C50 or larger 
carotenoid backbones can be found in nature. With the biosynthesis of larger 
carotenoid backbones, comes the potential to generate whole series of novel 
carotenoids using carotenoid-modifying enzymes. In this chapter, I will 
describe how I engineered a carotenoid synthase with larger C50, C55, or C60 
backbone synthase activity. I performed a directed evolution experiment in the 
search for a larger carotenoid backbone synthase using the previously 
discovered specificity-shifted mutant CrtMW38A as a parent. I identified a 
mutation at F233S [the 233rd residue phenylalanine (F) substituted to serine (S)] 
that further shifted the substrate specificity towards larger carotenoid 
backbones. The combination of this and other previously reported 
specificity-shifting mutations resulted in high activity for C50, C55, and C60 
carotenoid synthesis. 
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Chapter 3 Directed evolution of farnesyl diphosphate synthase 
3.1 Abstract 
Isoprenyl diphosphate synthases (IDSs) catalyze the consecutive 
condensation of five-carbon isopentenyl diphosphate with allylic diphosphates 
to generate the precursors to all of the isoprenoid compounds. Among the IDSs 
reported to date, specific natural C25PP synthases have not been isolated. I 
performed directed evolution on the farnesyl diphosphate (C15PP) synthase 
(FDS) Y81A mutant from Geobacillus stearothermophillus and searched for 
variants with high C25PP synthase activity. I identified two additional mutations, 
T121A and V157A, that altered the product specificity. These mutations alone 
did not drastically change the product specificity of FDS; however, combining 
these mutations with the previous identified mutation Y81A resulted in the 
efficient synthesis of C25PP in E. coli 
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Chapter 4 Specificity by pairwise matching: 
Specificity Stacking 
4.1 Abstract 
Synthetic biology aspires to construct novel metabolic pathways to 
useful, sometimes unnatural compounds. However, the promiscuous enzymes 
that enable molecular discovery can generate hyperbranched pathways that 
preclude specific production of the target novel product. I assembled a 
six-enzyme pathway in Escherichia coli for the 15-step synthesis of 
C50-astaxanthin, a non-natural purple carotenoid. The initial combination of 
promiscuous enzymes resulted only in a mixture of non-target carotenoids. I 
then evolved the variants of the first two pathway enzymes, isoprenyl 
diphosphate synthase and carotenoid synthase, with shifted specificity ranges. 
Judicious matching of selected variants resulted in specific production of C50 
carotenoid backbones, enabling the further extension and evolution of the 
unnatural C50 carotenoid pathway. The resultant pathway to C50-astaxanthin is 
comparably efficient (920 µg/gDCW) and selective (~90% of total carotenoids) 
to the native pathway for natural C40 astaxanthin (1,730 µg/gDCW, ~100% of 
total carotenoids), despite (and unlike the C40 pathway) containing not a single 
catalytically specific enzyme. Biosynthetic pathways, both natural and synthetic, 
can thus achieve product specificity without the burden of evolving exquisitely 
specific constituent enzymes. 
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Chapter 5 Directed evolution of carotenoid desaturase 
5.1 Abstract 
Carotenoid desaturases catalyze the desaturation reaction of 
carotenoid backbones. C50 carotenoid backbones can be successfully 
biosynthesized using the evolved enzyme variants described in the previous 
chapters. I performed a directed evolution of P. ananatis phytoene desaturase 
CrtI to obtain variants with high desaturation activity for the C50 backbone, 
thereby producing C50-desaturated carotenoids in E. coli. I obtained an efficient 
CrtI variant that desaturates the C50 backbone to produce a 6-step desaturated 
C50-lycopene as its main product. I will discuss the insights that I obtained for 
the step-number determination mechanism for CrtI. 
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Chapter 6 Expanding the scope of C50 carotenoid pathway 
6.1 Abstract 
Structurally novel non-natural carotenoids are gaining interest because of the 
pharmaceutical potential of carotenoids. In the former chapters, I successfully 
constructed the biosynthetic pathway for C50-lycopene in E. coli. Given the ‘locally 
specific’ nature of the carotenoid modifying (downstream) enzymes, I expected that the 
C50-lycopene could be recognized by the natural carotenoid enzymes from natural C40 
pathways. In this chapter, I co-expressed several locally specific enzymes to produce 
several non-natural C50 carotenoids. 
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Chapter 7 Production of carotenoids in Escherichia coli  
using squalene synthase 
7.1 Abstract 
The first committed steps of steroid/hopanoid pathways involve 
squalene synthase (SQS). Here, I report the Escherichia coli production of 
diaponeurosporene and diapolycopene, yellow C30 carotenoid pigments, by 
expressing human SQS and Staphylococcus aureus dehydrosqualene desaturase 
(CrtN). This study suggest that the carotenoid pigments are synthesized mainly 
via the desaturation of squalene rather than through the non-reductive 
condensation of prenyldiphosphate precursors, indicating the possible 
existence of a “squalene route” and a “lycopersene route” for C30 and C40 
carotenoids. Additionally, this finding yields a new method of colorimetric 
screening for the cellular activity of squalene synthases, which are major targets 
for cholesterol-lowering drugs. 
 
 
